Extranodal extension is an independent predictor of extensive nodal metastasis in T1 papillary thyroid cancer.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
환자: T1 papillary thyroid cancer (PTC)
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
[CONCLUSION] ENE is a strong independent predictor of ELM in patients with T1 PTC. Patients with ENE-positive nodes might need extensive neck dissection.
[PURPOSE] Extensive lymph node metastasis (ELM) can occur in some patients with T1 papillary thyroid cancer (PTC).
- p-value P < 0.001
- p-value P = 0.022
- 95% CI 0.93 to 0.99
APA
Hei H, Li Y, et al. (2022). Extranodal extension is an independent predictor of extensive nodal metastasis in T1 papillary thyroid cancer.. Langenbeck's archives of surgery, 407(4), 1647-1652. https://doi.org/10.1007/s00423-021-02425-0
MLA
Hei H, et al.. "Extranodal extension is an independent predictor of extensive nodal metastasis in T1 papillary thyroid cancer.." Langenbeck's archives of surgery, vol. 407, no. 4, 2022, pp. 1647-1652.
PMID
35146548 ↗
Abstract 한글 요약
[PURPOSE] Extensive lymph node metastasis (ELM) can occur in some patients with T1 papillary thyroid cancer (PTC). However, the risk factors for ELM in patients with T1 PTC have not been fully explored. In this study, we aimed to examine the association between extranodal extension (ENE) and ELM in patients with T1 PTC.
[PATIENTS AND METHODS] We identified 645 consecutive patients who had T1 PTC initially resected at our centre. Clinical and pathological data were reviewed. Univariate and multivariate logistic regression analyses were performed to identify the risk factors for ELM.
[RESULTS] ELM was identified in 3.9% of T1 PTC patients, and ENE was identified in 8.1% of patients. ENE was associated with male sex, large tumour size, more positive nodes, and comprehensive surgical treatment. In multivariate analysis, three variables were independently associated with ELM, including ENE (odds ratio [OR], 11.15; 95% confidence interval [CI], 4.54 to 27.30; P < 0.001), age (OR, 0.96; 95% CI, 0.93 to 0.99; P = 0.022), and tumour size (OR, 1.18; 95% CI, 1.06 to 1.31; P = 0.002). Bilateral multifocality and sex were not independently associated with ELM.
[CONCLUSION] ENE is a strong independent predictor of ELM in patients with T1 PTC. Patients with ENE-positive nodes might need extensive neck dissection.
[PATIENTS AND METHODS] We identified 645 consecutive patients who had T1 PTC initially resected at our centre. Clinical and pathological data were reviewed. Univariate and multivariate logistic regression analyses were performed to identify the risk factors for ELM.
[RESULTS] ELM was identified in 3.9% of T1 PTC patients, and ENE was identified in 8.1% of patients. ENE was associated with male sex, large tumour size, more positive nodes, and comprehensive surgical treatment. In multivariate analysis, three variables were independently associated with ELM, including ENE (odds ratio [OR], 11.15; 95% confidence interval [CI], 4.54 to 27.30; P < 0.001), age (OR, 0.96; 95% CI, 0.93 to 0.99; P = 0.022), and tumour size (OR, 1.18; 95% CI, 1.06 to 1.31; P = 0.002). Bilateral multifocality and sex were not independently associated with ELM.
[CONCLUSION] ENE is a strong independent predictor of ELM in patients with T1 PTC. Patients with ENE-positive nodes might need extensive neck dissection.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (4)
- Lymph node ratio independently associated with postoperative thyroglobulin levels in papillary thyroid cancer.
- Preoperative prediction of central neck metastasis in patients with clinical T1-2N0 papillary thyroid carcinoma.
- Macroscopic extranodal extension is an independent predictor of lung metastasis in papillary thyroid cancer.
- Male patients with papillary thyroid cancer have a higher risk of extranodal extension.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
- Key Considerations for Targeting in Pancreatic Cancer: Potential Impact on the Treatment Paradigm.
- Raman Spectroscopic Signatures of Hepatic Carcinoma: Progress and Future Prospect.
- The role of disulfidptosis-driven tumor microenvironment remodeling in pancreatic cancer progression.
- Effective use of PROs for survival prediction: Transformer-based modelling in NSCLC patients.
- Combining network pharmacology and experimental validation to study the action and mechanism of brusatol against lung adenocarcinoma.